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We provide a brief review of ﬁndings supporting a role for prenatal infection in the etiology
of schizophrenia. Our group and others have conducted birth cohort studies to address
whether in utero exposure to infectious agents, prospectively documented by biomarker
assays of archivedmaternal sera, and by detailed obstetric records, confer an increased risk
of schizophrenia in adult offspring. Prenatal exposure to inﬂuenza, elevated toxoplasma anti-
body, rubella, genital–reproductive infections, and other infections have been associated
with an increased risk of schizophrenia among offspring. Animal models have supported
these epidemiologic ﬁndings by revealing that maternal immune activation causes phe-
notypes analogous to those found in patients with schizophrenia. Given that exposure to
microbial agents are preventable or treatable, they suggest that interventions to diminish
the incidence of infection during pregnancy have the potential to prevent an appreciable
proportion of schizophrenia cases. Given the clear genetic component to schizophrenia,
future studies should include investigations of interactions between prenatal infection and
susceptibility genes in the pathogenesis of schizophrenia.
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INTRODUCTION
Schizophrenia is a complex neuropsychiatric disorder which has
both genetic and environmental components. Support for a role of
genes in the disorder derives from twin, family, and adoption stud-
ies (Riley and Kendler, 2005). The strongest evidence among these
study designs is the twin study, in which the concordance rate of
a disorder is compared between monozygotic (MZ) and dizygotic
(DZ) twins. These studies have demonstrated marked increases in
twin concordance in MZ compared to DZ twins. Since MZ twins
are believed to share all of their genes, compared to DZ twins,
who share only about 50% of their genes, these studies are consis-
tent with an important role of genes in schizophrenia. In addition,
numerous studies have identiﬁed strong evidence for associations
between several susceptibility alleles and schizophrenia (Gejman
et al., 2011).
Notably, however, the concordance rate for schizophrenia in
MZ twins is approximately 50–60% indicating that environmental
factors likely play a signiﬁcant role in susceptibility to this disor-
der (Riley and Kendler, 2005). Moreover, twin studies do not yield
precise measures of heritability because the additive component
of the model, on which that estimate is based, includes gene–
environment interaction (Schwarts and Susser, 2006). Hence,
increased attention is being paid to the study of environmental
factors in schizophrenia, in order to account for the unexplained
heritability. It is also worth noting, however, that recent work sug-
gests that at least some of this unexplained genetic risk may be
a result of copy number variants (CNVs) and other rare vari-
ants, which can arise de novo (Buizer-Voskamp et al., 2011), and it
is generally believed that whole genome sequencing will identify
many if not most of these rare alleles.
Much of the work on environmental exposures in schizophre-
nia has focused on prenatal infection. Initial clues indicated that
births during the winter and spring months and in urban areas
were related to an increased risk of the disorder (Brown and Derk-
its, 2010). This suggested that infections, which vary by season
and spread more quickly in urban regions, may contribute to
these associations. Schizophrenia is generally believed to have a
strong neurodevelopmental component to its etiology (Wadding-
ton, 1993), and congenital infection has been well documented
as a cause of known neuropsychiatric disorders (Remington and
Klein, 2006). Hence, epidemiologic investigations have examined
the role of prenatal infection in schizophrenia.
Initial studies utilized ecologic data on inﬂuenza and other
epidemics in populations to deﬁne the timing of exposure dur-
ing pregnancy (for review, see Brown and Derkits, 2010). While
several papers suggested potential associations between inﬂuenza
epidemics and schizophrenia among those who were in utero
during the second trimester of pregnancy, a number of subse-
quent studies failed to replicate these ﬁndings. These studies were
limited, however, by imprecise measures of exposure given that
inﬂuenza infection was not documented in individual pregnan-
cies. Hence, our group and others have initiated more reﬁned
approaches including birth cohort studies to address whether
prenatal infection is a risk factor for schizophrenia.
BIRTH COHORT STUDIES OF PRENATAL INFECTION AND
SCHIZOPHRENIA
Birth cohort studies offer numerous advantages in research on
risk factors for psychiatric disorders such as schizophrenia. A birth
cohort is a collection of individuals or pregnancies from a speciﬁc
time period and place, recruited at the time of, or prior to birth
(Rothman and Greenland, 1998). In a typical birth cohort study,
baseline data and often biological specimens are collected dur-
ing pregnancy, birth, and the neonatal period, and are archived
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for future studies, and the cohort is followed over time for the
development of the disorder of interest. Birth cohort studies offer
numerous advantages over ecologic studies, in that the exposure
of interest, in this case infection, can be documented in individual
pregnancies and related to the outcome, speciﬁcally schizophre-
nia. These studies can also capitalize on serologic biomarkers of
infection by assays for speciﬁc antibodies or measures of immune
function. Furthermore,most of these studies do not rely on mater-
nal recall of the infection after the pregnancy, which can lead
to inaccurate or biased reporting, particularly if the outcome
is assessed after the diagnosis of schizophrenia is made. Rather,
exposures can be documented prospectively, which provides more
accurate measurement of the infection and cannot be inﬂuenced
by the outcome since it occurs long after assessment of the expo-
sure. We ﬁrst review seroepidemiologic studies of infection and
schizophrenia, and then discuss other birth cohort studies that
have examined this question.
SEROEPIDEMIOLOGIC STUDIES OF PRENATAL INFECTION
In the Child Health and Development Study (CHDS) birth cohort,
our group has investigated the relationship between several prena-
tal infections and schizophrenia risk (Brown and Derkits, 2010).
An advantage of this cohort was the use of archived maternal
serum specimens which could be assayed for antibody to differ-
ent infections that were plausibly considered to represent putative
risk factors for schizophrenia. All subjects were born from 1959
to 1967 in Alameda County, California and were followed up, in
collaboration with the Kaiser Permanente Division of Research
and the CHDS cohort, using electronic databases, structured
research interviews, and psychiatric records. Two other stud-
ies have investigated in utero infection and schizophrenia using
archived biospecimens, the Collaborative Perinatal Project (Buka
et al., 2001a), which was recruited during the same birth years
as the CHDS, and also capitalized on maternal serum specimens,
and a study from a Danish cohort, which had ﬁlter paper blood
spots collected within the ﬁrst week of life (Mortensen et al.,
2007).
These studies have yielded evidence for a relationship between
several infectious agents and immune biomarkers and schizophre-
nia risk. In theCHDSbirth cohort,we demonstrated that exposure
to inﬂuenza during early to mid-pregnancy was related to a three-
fold increased risk of schizophrenia among offspring (Brown et al.,
2004a). In this cohort, we also demonstrated that elevated IgG
antibody to Toxoplasma gondii (T. gondii) was related to a greater
than twofold elevation of schizophrenia risk (Brown et al., 2005).
This ﬁnding was essentially replicated in the Danish study men-
tioned above, in which increased IgG antibody to this infection
in infant ﬁlter paper blood was related to increased schizophrenia
risk (Mortensen et al., 2007). In a study of maternal cytokines, our
group demonstrated that maternal levels of interleukin-8 (IL-8)
was increased twofold in pregnancies that led to schizophrenia,
compared to healthy controls (Brown et al., 2004b). In the CPP
cohort, maternal exposure to the cytokine tumor necrosis-factor
alpha (TNF-alpha) was related to an increased risk of schizo-
phrenia (Buka et al., 2001b). Both the CPP and CHDS birth
cohorts have investigated the relationship between maternal anti-
body levels to herpes simplex viruses (HSV) and schizophrenia.
In two studies from the CPP, maternal HSV-2 IgG antibody lev-
els, and seropositivity to this infection, respectively, were related
to an elevated risk of schizophrenia (Buka et al., 2001a, 2008).
These ﬁndings were not replicated in the CHDS birth cohort
(Brown et al., 2006), although they were replicated by a recent
study on ﬁlter paper blood spots from Denmark (Mortensen et al.,
2010).
In the Rubella Birth Defects Evaluation Project (RBDEP), a
birth cohort with serologic documentation of prenatal exposure to
rubella,we demonstrated that the prevalence of schizophrenia and
other schizophrenia spectrum disorders was over 20%,which sug-
gests a 10- to 15-fold increase in risk (Brown et al., 2001). We also
observed that a decline in IQ between childhood and adolescence
was present in a markedly greater proportion of rubella exposed
cases compared to rubella exposed controls, further supporting
the plausibility of the association.
FINDINGS FROM OTHER BIRTH COHORT STUDIES OF INFECTION
Other birth cohort studies, utilizing databases from obstetric
records have demonstrated relationships between prenatal infec-
tion and schizophrenia. An advantage of these studies is that
infections that have been documented by physicians are often used
to deﬁne exposure status, and they can be conducted more con-
veniently than studies of biomarkers, by record linkages between
sources of data on exposure, including records from pregnancy
and birth, and sources of data on outcomes, including psychiatric
registries or direct interviews.
These studies have revealed several additional ﬁndings. In the
CHDS cohort, periconceptional exposure to maternal genital–
reproductive infection was shown to be associated with a ﬁvefold
increase in schizophrenia risk (Babulas et al., 2006), and second
trimester exposure to maternal respiratory infection conferred
a twofold elevation in risk (Brown et al., 2000). In the Copen-
hagenPerinatal Cohort,born 1959–1961,an associationwas found
between maternal bacterial infections in the ﬁrst and second
trimesters and risk of schizophrenia, with approximately twofold
increases in the effects (Sørensen et al., 2009). In a study based on
data from women treated for urinary tract infections during preg-
nancy in Helsinki, Finland from 1947 to 1990, an interaction was
observed between exposure to pyelonephritis and a family history
of schizophrenia (Clarke et al., 2009).
POTENTIAL CAUSAL MECHANISMS
These ﬁndings have the potential to elucidate neurodevelopmental
mechanisms by which infections or other putative risk factors may
increase susceptibility to schizophrenia. Formany of the infections
reviewed above, it is unlikely that the effects can be explained by
a direct disruption of the fetal brain by these agents given that
some, such as inﬂuenza, do not cross the placenta, or others,
including elevated toxoplasma IgGwere observed in the absence of
active infection. We ﬁrst consider whether there may be a mech-
anism in common to different infections that has been related
to schizophrenia in the birth cohort studies reviewed above, and
that does not require direct fetal invasion. It is well known that
virtually all infections induce the release of cytokines, molecules
that orchestrate the host immune response. These include pro-
inﬂammatory cytokines, such as interleukin-6 (IL-6), IL-8, and,
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TNF-alpha. The hypothesis that these molecules may mediate the
effects of infection on schizophrenia risk (Gilmore and Jarskog,
1997), has been tested in many studies of maternal immune
activation (MIA) in animal models (for review see Patterson,
2009). In these studies an agent known to produce MIA, such
as polyinosinic:polycytidylic acid (poly I:C), which mimics a viral
infection, or lipopolysaccharide (LPS), which mimics a bacterial
infection are administered to pregnant rodents, and the offspring
are assessed for behavioral, neurochemical, and other phenotypes
observed in patients with schizophrenia. MIA exposure causes
abnormalities in behaviors and neurochemical responses elicited
by excess dopamine and neurophysiologic abnormalities includ-
ing latent inhibition deﬁcits, which were reversed by clozapine.
MIA also led to increased sensitivity of the offspring to an antago-
nist of the N -methyl-d-aspartic acid antagonist MK-801. These
ﬁndings are consistent with neurochemical abnormalities that
have been robustly implicated in schizophrenia (Owen and Simp-
son, 1995). Intriguingly, the effects of IL-6 on such phenotypes
in offspring were prevented by administration of anti-IL-6 anti-
body or in an IL-6 genetic knockout (Smith et al., 2007). As
noted above, maternal sera elevations in two pro-inﬂammatory
cytokines, IL-8 and TNF-alpha, were associated with schizo-
phrenia in previous studies (Buka et al., 2001b; Brown et al.,
2004b). In more recent work, maternal inﬂuenza infection was
found to cause reduced cortical gray matter volume, decreased
white matter in the parietal cortex, and maternal IgG was corre-
lated with ventricular enlargement (Short et al., 2010). Prenatal
immune activation also interacts with mutant DISC1 to produce
alterations of social behavior, modulation of secretion of fetal
inﬂammatory cytokines, and other effects (Abazyan et al., 2010).
MIA impairs several aspects of synaptic function and synapto-
physin levels, though does not cause neuronal loss, consistent with
observations in postmortem schizophrenia brain (Oh-Nishi et al.,
2010) and alters long-range neural synchrony (Dickerson et al.,
2010).
A second possible scenario, which may co-exist with the “com-
mon mechanism” hypothesis, is that different prenatal infections
may act by unique mechanisms to increase risk of schizophre-
nia. Each of these agents differ in their antigenicity, symptoms,
and biological effects, and may therefore have differential conse-
quences on fetal brain development relevant to the neurobiology
of schizophrenia. For example, rubella is known to directly infect
the fetal brain, leading to a potent inﬂammatory response which
causes neuronal death, gliosis, and a disruption of mitosis (Brown
et al., 2001); this differs from an agent such as inﬂuenza, which
does not appear to cross the placenta.
Clinical studies of schizophrenia are providing further evidence
that prenatal infection alters structure and function of the brain.
In utero exposure to infection has been associated with executive
function deﬁcits, and larger size of the cavum septum pellu-
cidum, a neuromorphologic marker of dysgenesis, in patients with
schizophrenia (Brown et al., 2009a,b). More recent data indicates
that maternal elevated interleukin-8 is associated with ventric-
ular enlargement in schizophrenia cases (Ellman et al., 2010)
and maternal genital–reproductive infections are related to ver-
bal memory, neuromotor, and working memory deﬁcits (Brown
et al., 2011).
IMPLICATIONS OF THE FINDINGS FOR PREVENTION AND
GENETICS RESEARCH
One clear implication of these ﬁndings is that, if replicated, they
suggest that straightforward public healthmeasuresmay result in a
reduction in the incidence of schizophrenia. Inﬂuenza vaccination,
improved hygiene to prevent T. gondii infection, and antibiotics to
treat genital/reproductive infections are strategies that are already
being employed in both pregnant and non-pregnant populations.
Using the population prevalences of these putative risk factors
in the studies from the CHDS cohort, we calculated, for each
of these infections, the attributable proportion, or the percent-
age of cases in the population who would not have developed
the disease if the exposure were eliminated (Brown and Derkits,
2010). We found that complete elimination of each of these three
classes of infections would prevent as many as 33% of schizophre-
nia cases from the population. Although complete prevention of
all of these infections is clearly not realistic, it nonetheless sug-
gests that greater attention to reducing their incidence could have
an appreciable effect on reduction of schizophrenia risk in the
population.
While molecular genetic and genetic epidemiologic studies
have great potential to elucidate the pathogenic mechanisms that
lead to the disorder, it is our view (Brown and Derkits, 2010),
and those of others (van Os et al., 2008) that their promise can
only be fully realized by studies of gene–environment interaction.
Studies of individual susceptibility genes generally have small to
modest effects on risk, and interactions between genetic muta-
tions and environmental factors have been proposed to account
for the majority of liability to most complex diseases such as
schizophrenia (van Os et al., 2008). Interestingly, in three large
genome-wide association studies of schizophrenia, genetic vari-
ants in the extended major histocompatibility complex (MHC)
reached genome-wide signiﬁcance (Purcell et al., 2009; Shi et al.,
2009; Stefansson et al., 2009), one of the few replicated genetic
ﬁndings. These genes are critical to not only immune function,
but also synaptic function, remodeling, and plasticity (Boulanger,
2009). Hence, the study of environmental factors may increase
the likelihood of identifying susceptibility genes that interact with
environmental exposures such as prenatal infection.
SUMMARY AND DIRECTIONS FOR FUTURE RESEARCH
Ecologic studies provided suggestive evidence that prenatal infec-
tion may be a risk factor for schizophrenia. Several birth cohort
studies, which have capitalized on methodologic improvements to
these earlier studies, have yielded intriguing evidence supporting
this association. These infections may act via a common pathway,
such as the cytokine response, unique mechanisms, or a combi-
nation of these pathways to elevate susceptibility to this disorder.
Animal models have documented that MIA leads to abnormal-
ities of brain and behavior that are consistent with phenotypes
observed in schizophrenia. These ﬁndings have clear public health
implications given that interventions already exist to prevent and
treat these infections.
We suggest several approaches aimed at conﬁrming and elab-
orating upon the ﬁndings to date. First, it will be necessary to
replicate these results in other samples, ideally in other birth
cohortswith prospectivemeasures of infection. Second,we suggest
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that future studies examine both prenatal infection and puta-
tive susceptibility genes within the same cohorts in order to
investigate gene–environment interaction. This may increase the
probability of identifying both in utero infectious microbes and
genetic mutations that increase risk of schizophrenia. Third, we
advocate for further translational research aimed at validating
infection-induced phenotypes and exploring causal mechanisms
of this disorder. Finally, we suggest that interdisciplinary alliances
between experts in epidemiology, molecular and clinical neuro-
science, and genetics will allow us to fully realize the promise of
identifying infectious and other environmental and genetic origins
of schizophrenia.
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